Immunome, Inc. · 4 days ago
Senior Research Associate, Antibody Sciences
Bothell, WA
Full-time
Onsite
Senior Level
$108K/yr - $137K/yr
6+ years expImmunome, Inc. is a clinical-stage targeted oncology company committed to developing innovative cancer therapies. The Senior Research Associate, Antibody Sciences will be responsible for the characterization and functional evaluation of novel antibodies, executing screening assays, and collaborating with cross-functional teams to advance the antibody discovery platform.
BiopharmaBiotechnologyMedicalPharmaceutical
Responsibilities
Design, execute, and analyze cell-based assays to support antibody screening and characterization, with an emphasis on cytotoxicity and internalization
Perform multicolor flow cytometry, including cell sorting and magnetic bead separation (MACS/Stemcell)
Maintain mammalian tissue culture, including over expressing, native expressing tumor and primary cell cultures
Generate and characterize engineered cell lines, including overexpression and knockout models
Develop, validate, and qualify reagents and tools required for antibody screening workflows
Learn and apply Octet BLI for reagent validation and binding kinetics characterization
Support single-cell workflows, including experience with the 10x Genomics platform
Analyze, interpret, and summarize experimental data and communicate results and implications to project teams
Collaborate with colleagues across biology, chemistry, pharmacology, and translational medicine to achieve project goals
Organize experimental data to enable effective collaboration and knowledge sharing across research teams
Maintain detailed and accurate electronic laboratory notebooks documenting procedures, results, and conclusions
Prepare and present research findings to internal teams and contribute to project updates and strategic discussions
Stay informed on advances in techniques for producing and characterizing protein therapeutics
Proactively seek opportunities for professional development and contribute to the scientific growth of the Antibody Sciences team
Qualification
Required
Bachelor's or Master's degree in molecular biology, biochemistry, biophysics, or a related field
A minimum of 8 years of experience in the biotechnology or pharmaceutical industry, or a minimum of 6 years of experience with a Master's degree
Hands-on experience with flow cytometry, cell sorting, and cell-based assay development and execution
Preferred
Experience with mammalian tissue culture, including primary cell culture
Experience generating overexpressing and knockout cell lines
Experience with cytotoxicity- and internalization-focused screening assays
Experience with Octet BLI for kinetics and reagent validation
Experience with single-cell platforms such as 10x Genomics
Strong experimental design, troubleshooting, and scientific problem-solving skills
Ability to analyze, summarize, and clearly communicate complex datasets and scientific conclusions
Highly organized and detail-oriented with strong documentation practices
Demonstrated ability to work independently while contributing effectively within cross-functional research teams
Proficiency with Benchling, GraphPad Prism, Microsoft Excel, PowerPoint, and Word
Familiarity with flow cytometry analysis software such as FlowJo
Strong written and verbal communication skills, including preparation and delivery of internal presentations
Company
Immunome, Inc.
Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted therapies designed to improve outcomes for cancer patients.
51-200 employees
H1B Sponsorship
Immunome, Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (1)
Funding
Current Stage
Public CompanyTotal Funding
$998.85MKey Investors
JPEO-CBRNDU.S. Department of DefenseRobin Hood Ventures
2025-12-16Post Ipo Equity· $400M
2025-01-29Post Ipo Equity· $150M
2024-02-13Post Ipo Equity· $230M
Leadership Team
Clay Siegall
President and CEO
Purnanand D. Sarma
President & CEO
Recent News
2026-01-09
BioWorld Financial Watch
2025-12-19
Company data provided by crunchbase